Teriparatide is an osteosynthesis agent, a human parathyroid hormone merger, which helps regulate calcium metabolism and promotes the synthesis of new bone, which can rebuild bone, and is used in patients with severe osteoporosis. Mainly postmenopausal patients with severe osteoporosis who are facing fractures. Or patients with severe osteoporosis who have been taking hormones for a long time and are prone to fractures. For such patients, it needs to be applied continuously for six years with annual injections. This drug is not used to prevent fracture osteoporosis and patients with mild osteoporosis. Because this drug also has some side effects, mainly muscle spasms in the legs and face, as well as redness, swelling, heat and pain at the injection site, and in some patients it can cause depression. So with this drug, you need to go to a regular hospital endocrinology department by a professional physician to prescribe, according to the specific circumstances of the individual application, weighing the pros and cons.